Sponsor Pipeline

Wan-Guang Zhang Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06822985 QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular Carcinoma HCC - Hepatocellular Carcinoma Not Yet Recruiting
Not specified
NCT07077798 Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver… Hepatocellular Carcinoma (HCC) Not Yet Recruiting
Disease Areas
Liver Cancer (2)
Get alerts when Wan-Guang Zhang's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free